Loading, please wait...
Obesity-related conditions are among the leading causes of preventable, premature death, include heart disease, stroke, type 2 diabetes, and certain types of cancer. Join Dr. Erica Crannage for a one-hour live presentation where she reviews the currently available FDA-approved medications for the treatment of obesity. Multi-modal approaches to managing overweight and obesity in adults, including lifestyle modifications, pharmacotherapy, and bariatric surgery will also be discussed. Dr. Crannage will conclude by providing patient counseling strategies such as lifestyle modifications, behavioral intervention, follow-up, as well as the need to monitor for efficacy and toxicity of pharmacologic agents.
To learn more about this activity, including speaker information and learning objectives, expand the module below (click the +). Pharmacists can earn 1.00 contact hour of knowledge-based CE credit at the completion of this activity.
This session will be held live. All pharmacists are welcome to attend, free of charge!
Refreshments will be served before and after the CE activity.
Location: Pangea Kitchen, 111 S Green River Rd e, Evansville, IN 47715
CPE Credit: To earn 1.00 hours of CPE credit, please complete the evaluation that will be emailed to you at the conclusion of the event. Please complete this evaluation within 7 days. The CPE Administrator will submit each participant’s NABP number and date of birth combination to CPE Monitor for continuing education credit, no later than two weeks after this virtual presentation.
The NABP ePID and date of birth fields must be accurate for credit reporting to occur. Participants are encouraged to check their NABP eProfiles for receipt of credit within two weeks of submitting their evaluation(s). If a participant notices an error in credit on their NABP e-profile, they are encouraged to contact Nicole Fields at Nicole.Fields@uhsp.edu soon as possible. To best comply with ACPE's CE credit reporting policy, the University of Health Sciences and Pharmacy in St. Louis is unable, for any reason, to award or correct CE credit if more than 60 days have passed from the event.
After one week, the evaluation will close and CPE credit may no longer be claimed. If the deadline is missed or if a CE credit correction must be issued, an additional fee may be incurred for late submission, please see our policy, located on the FAQ page for details. The evaluation will close April 13, 2022 at 11:59 PM (CST).
Date: Apr 6, 2022 06:30 AM - 07:30 AM
Fee
$0.00
CE Hours
1.00
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
|
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To learn more about the specific program information, including universal activity numbers (UAN's) and learning objectives, please expand the modules below. Following successful completion of an evaluation, CE credit will be automatically reported to NABP through the CPE Monitor system, using the NABP ePID numbers and date of birth (MMDD) stored in participants' user profiles. Follow this link to learn more about CPE Monitor and the credit reporting process » Participants are responsible for ensuring receipt of credit; no credit can be corrected or awarded if more than 60 days have passed from the date of the event or if the home study is expired.
It is the policy of St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in this program are expected to disclose to the program audience any real or apparent conflicts of interest related to the content of the presentation.
|
Requirements for CE Credit
To claim credit for this session, participants must complete the following steps:
- Visit this site. Make sure you are logged in and registered before proceeding.
- Complete an evaluation by clicking the green evaluation button
- Enter the evaluation code that was given to you at the end of the session you attended.
- Answer all questions honestly - we appreciate your feedback! All responses are stored anonymously.
- Click submit. As soon as you submit, a report containing the NABP ePID and DOB stored in your profile will be automatically sent to CPE Monitor.
- Please allow up to 48 hours for processing. Your credit should appear in your NABP profile online.
If you experience difficulty, please contact our office so that we may assist you. We are happy to help!
Participants are responsible for ensuring accuracy of credit reporting and receipt of credit. It is recommended that participants log on and review the information under "my account" prior to submitting the evaluation. NABP ePID and date of birth must be accurate for credit reporting to occur. Evaluations cannot be reopened after 14 days.
Participants are encouraged to check their NABP e-profiles for receipt of credit within one week of submitting their evaluation(s). If a participant notices an error in credit on their NABP e-profile, they are encouraged to contact our office as soon as possible. To best comply with ACPE's CE credit reporting policy, the University of health Sciences and Pharmacy in St. Louis is unable, for any reason, to award or correct CE credit if more than 60 days have passed from the event.
Learn more! Click the + symbol to expand.
The presentation will begin with an review of the currently available, FDA-approved medications for treatment of obesity. The presentation will then explore the multi-modal approach to managing overweight and obesity in adults, including lifestyle modifications, pharmacotherapy, and bariatric surgery. As pharmacists are in a unique position to counsel patients on lifestyle modifications, provide behavioral intervention and followup, and monitor for efficacy and toxicity of pharmacologic agents, the presentation will outline the most pertinent counseling points for patients.
Objectives
- Define overweight and obesity and the potential health benefits of losing excess weight
- Evaluate currently FDA-approved weight loss medications for appropriateness, contraindications, efficacy (included indications for dose adjustments), adverse effects, drug interactions, and compliance
- Develop counseling points and strategies to address medication issues in patients who have had bariatric surgery
Speaker(s)/Author(s)
|
Erica Crannage, Pharm.D., FCCP, BCPS, BCACP
|
Activity Number
0033-0000-22-009-L01-P
Date:
04/06/22
Time:
06:30 PM - 07:30 PM
CE Hours
1.00
